Millstone Evans Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
2,267
-735
-24% -$353K 0.61% 31
2026
Q1
$1.48M Hold
3,002
0.89% 22
2025
Q4
$1.74M Sell
3,002
-45
-1% -$25.4K 1.02% 18
2025
Q3
$1.48M Buy
3,047
+86
+3% +$40K 0.94% 19
2025
Q2
$1.2M Buy
2,961
+74
+3% +$30.9K 0.82% 20
2025
Q1
$1.44M Buy
2,887
+6
+0.2% +$3.25K 0.97% 21
2024
Q4
$1.5M Buy
+2,881
New +$1.58M 1.02% 18

Other funds holding TMO

Millstone Evans Group's TMO Position: Q2 2026 in Review

Millstone Evans Group reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q2 2026, selling an estimated $353K and leaving 2,267 shares worth $1.14M. The position accounts for 0.61% of the portfolio, ranked #31.

Millstone Evans Group first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.74M in Q4 2025. 2,215 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Millstone Evans Group held 2,267 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
  • Millstone Evans Group sold 735 Thermo Fisher Scientific shares in Q2 2026, an estimated $353K.
  • Thermo Fisher Scientific made up 0.61% of Millstone Evans Group's portfolio in Q2 2026, its #31 holding.
  • Millstone Evans Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's Thermo Fisher Scientific position peaked at $1.74M in Q4 2025.
  • 2,215 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.